1. Catalogs
  2. Nanodigmbio
  3. Nanodigmbio-NGS NEXome Mini Panel v1.0

Nanodigmbio-NGS NEXome Mini Panel v1.0

Nanodigmbio-NGS NEXome Mini Panel v1.0

Nanodigmbio-NGS NEXome Mini Panel v1.0

Product catalog summary
Overview
The NEXome Mini Panel v1.0 is a targeted genomic sequencing tool designed to focus on the exome regions associated with clinical inherited diseases. It covers a 16.1 Mb genomic region, involving 5,650 genes related to over 4,000 genetic disorders. This panel aims to improve diagnostic accuracy and efficiency while reducing costs compared to whole exome sequencing.

Performance
  • Highly Targeted: Focuses on clinically significant regions, enhancing the detection of genetic variations within target genes.
  • High Accuracy: Utilizes probe hybridization capture to provide reliable data for research.
  • High Efficiency: Reduces data analysis time and turnaround time compared to whole exome panels.
  • Cost-effective: Limits sequencing to clinically significant regions, reducing costs.

Background
Whole exome sequencing offers advantages in diagnostic accuracy and discovering new variations but faces challenges like insufficient coverage depth and large data volumes. The NEXome Mini Panel addresses these by focusing on core gene regions, providing a more efficient and cost-effective solution.

Features
The panel demonstrates high mappability, on-target rate, and target coverage, with minimal GC bias, as shown in performance figures. It is designed for use with the Illumina Novaseq 6000 platform.

High Confidence Variant Calls
The panel shows high sensitivity and positive predictive value (PPV) for mutation identification, ensuring reliable variant detection.

Efficiency and Cost-effectiveness
The NEXome Mini Panel reduces the amount of raw sequencing data required, minimizing costs while maintaining coverage depth. It offers a significant reduction in data volume compared to the NEXome Core Panel.

Ordering Information
The NEXome Mini Panel v1.0 is available in two configurations: 96 reactions (Catalog# 1001881) and 16 reactions (Catalog# 1001882).

Statement
For research use only. Not for diagnostic procedures. Reproduction or translation of this document requires written permission from Nanodigmbio Pte. Ltd.
See more

Catalog excerpts

Nanodigmbio-NGS NEXome Mini Panel v1.0-1

NEXome Mini Panel v1.0 Compared with traditional detection technologies for inherited diseases, whole exome sequencing has significant advantages in improving diagnostic accuracy, discovering new types of variations, and conducting deep sequencing. However, whole exome sequencing faces challenges in clinical inherited diseases detection, such as the loss of information in important variant regions due to insufficient coverage depth. Additionally, the vast amount of sequencing data poses challenges for bioinformatics analysis. Therefore, Nanodigmbio launched the NEXome Mini Panel v1.0, designed specifically for clinical inherited diseases. By focusing on core gene regions, this panel provides a more efficient and cost-effective solution for clinical genetic disease detection. NEXome Mini Panel v1.0 focuses on the exome associated with clinical inherited diseases, with probe coverage spanning a 16.1 Mb genomic region involving 5,650 clinically significant genes and encompassing over 4,000 genetic disorders. In comparison to the whole exome panel, the NEXome Mini Panel can be used to rapidly and efficiently detect pathogenic genetic variations within target genes in the human genome. This not only reduces sequencing costs but also significantly shortens data analysis time. Highly Targeted: Focuses on the exome associated with clinical inherited diseases, covering a 16.1 Mb genomic region, involving 5,650 genes related to over 4,000 clinical genetic disorders. High Accuracy: Based on the probe hybridization capture principle, it can accurately detect genetic variations within target genes, providing reliable data support for subsequent research. High Efficiency: Compared to the whole exome panel, the NEXome Mini Panel can rapidly detect pathogenic genetic variations within target genes, thereby reducing data analysis time and minimizing turnaround time. Cost-effective: Aim to only include clinically significant regions specifically related to inherited diseases, effectively reducing sequencing costs. Normalized coverage Capture Performance Figure 1. Capture performance of NEXome XP Panel v1.0. Cell Line gDNA Standard (Coriell, NA12878) were used to prepare library with the NadPrep DNA Library Preparation Kit (for Illumina®). NEXome Mini Panel v1.0 were used to complete hybridization capture. The BWA was used for alignment of raw reads to the reference genome (hg38). A. Mappability, On-target rate, and target coverage; B. GC Bias. Note: Sequencing platform: Illumina Novaseq 6000,PE150.

 Open the catalog to page 1
Nanodigmbio-NGS NEXome Mini Panel v1.0-2

High Confidence Variant Calls Sensitivity Calling rate (%) Figure 2. Sensitivity and positive predictive value (PPV) of NEXome Mini Panel Covered region Covered region More Efficient and Cost-effective A NEXome Core Panel NEXome Mini Panel Mean depth Figure 3. The NEXome Mini Panel reduces sequencing raw data to minimize costs. A. Minimum amount of raw data required for the NEXome Mini Panel and NEXome Core Panel to achieve a specific depth; B. Coverage region and relationship between the NEXome Mini Panel and NEXome Core Panel. Ordering Information Product NEXome Mini Panel v1.0, 16 rxn NEXome...

 Open the catalog to page 2

All Nanodigmbio catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.